Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries

BACKGROUND AND AIMS: For children with heterozygous familial hypercholesterolaemia (HeFH), European guidelines recommend consideration of statin therapy by age 8–10 years for those with a low density lipoprotein cholesterol (LDL-C) >3.5 mmol/l, and dietary and lifestyle advice. Here we compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswami, Uma, Futema, Marta, Bogsrud, Martin P., Holven, Kirsten B., Roeters van Lennep, Jeanine, Wiegman, Albert, Descamps, Olivier S., Vrablik, Michal, Freiberger, Tomas, Dieplinger, Hans, Greber-Platzer, Susanne, Hanauer-Mader, Gabriele, Bourbon, Mafalda, Drogari, Euridiki, Humphries, Steve E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949888/
https://www.ncbi.nlm.nih.gov/pubmed/31809987
http://dx.doi.org/10.1016/j.atherosclerosis.2019.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949888/
https://www.ncbi.nlm.nih.gov/pubmed/31809987
http://dx.doi.org/10.1016/j.atherosclerosis.2019.11.012

Ejemplares similares